NCM · Biotechnology

ELAB (ELAB) Stock

$0.92 +2.21% NCM: ELAB Healthcare

Valuation

MetricValue
Price$0.92
Market Cap$1.78M
P/E Ratio0.00
P/B Ratio0.42
P/S Ratio2.53
EPS (TTM)$-378.74
52-Week High$309.89
52-Week Low$0.87
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-100.00%
ROA-61.54%
ROCE-87.50%
Gross Margin-700.00%
Operating Margin-700.00%
Net Margin-8.73%
Debt/Equity0.60
Current Ratio1.75

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$1.0M$2.0M$2.0M$1.0M
Operating Profit$-1.0M$-2.0M$-1.0M$-2.0M$-7.0M
Net Profit$-1.0M$-2.0M$-4.0M$-6.0M$-8.0M
EPS$-6.96$-15.84$-0.40$-6592.32$-378.74
Op Margin-94928.7%-233.4%-66.6%-75.7%-1250.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$2.0M$5.0M$9.0M$13.0M
Total Liabilities$0$1.0M$1.0M$2.0M$5.0M
Cash$0$1.0M$3.0M$4.0M$5.0M
Borrowings$0$0$0$0$3.0M

Latest News

NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications GlobeNewswire · Jul 13, 2026 PMGC Holdings Advances EL-22 FACS Analysis to Support Manufacturing Comparability InvestorsHub · Jul 10, 2026 NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression GlobeNewswire · Jul 10, 2026 PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace GlobeNewswire · Jul 6, 2026 NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences GlobeNewswire · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-2.0M$-5.0M$-5.0M$-6.0M
Investing Cash Flow$0$0$0$-1.0M$-3.0M
Financing Cash Flow$0$0$-1.0M$0$4.0M
Net Cash Flow$0$1.0M$2.0M$1.0M$1.0M
Free Cash Flow$-1.0M$-2.0M$-5.0M$-5.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-246.63%
Quick Ratio1.41
Interest Coverage-7.00
Return 1Y-99.44%
Return 3Y—
Return 5Y—

Ownership

Insiders Held9.99%
Institutions Held1.92%
Institutions Float Held2.13%
Institutional HolderSharesReport Date
Jane Street Group, LLC31,5942026-03-31
Schonfeld Strategic Advisors Llc14,8002026-03-31
Morgan Stanley15,0002026-03-31
UBS Group AG1,3022026-03-31
IFP Advisors, Inc1,0002026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About ELAB

ELAB is led by CEO Graydon Bensler, employs 2 people, headquartered in US, publicly traded since 2023.

ELAB stock trades at $0.92 with a market capitalization of $1.78M. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.42, price-to-sales of 2.53. Over the past 52 weeks the stock has ranged between $0.87 and $309.89, and currently trades 99.7% below its 52-week high.

On profitability, ELAB generates a return on equity (ROE) of -100.00%, return on capital employed of -87.50%, an operating margin of -700.00%, a net profit margin of -8.73%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides